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Abstract—In this work, a unified representation of all the time-
varying dynamics is accomplished with a Lagrangian framework
for analyzing regularized dynamical optimal mass transport
(OMT) derived flows. Our Lagrangian framework is also ap-
plicable to the Fisher-Rao regularization because, as we show,
it is equivalent to our regularized dynamical OMT formulation.
The advantage of the Lagrangian framework is that the time-
varying trajectories and particle attributes are displayed in a
single visualization. This provides a natural capability to identify
and distinguish flows under different conditions. Applying our
Lagrangian analysis to the glymphatic system, we successfully
distinguish between flow patterns under two different anesthetics.
We should also note that the Fisher-Rao regularization makes
direct contact with some of the very nice recent work on entropic
regularization for the computation of optimal mass transport as
well as the Schro¨dinger bridge theory. The latter provides a
stochastic aspect to the approach described in the present work.
Index Terms—Lagrangian optimal mass transport, Glymphatic
system.
I. INTRODUCTION
THE problem of optimal mass transport (OMT) datesback to Monge in 1781, who posed the problem of
finding the minimal transportation cost for moving a pile
of soil from one location to another. OMT was given a
modern and relaxed formulation in the work of Kantorovich,
and so is now known as the Monge–Kantorovich problem.
Applications include image processing and computer vision,
econometrics, fluid flows, statistical physics, machine learning,
expert systems, and meteorology; see [30], [31], [39] and the
many references therein.
The dynamical version of OMT, put forth by Benamou
and Brenier [1], opened up new possibilities for numerical
solutions and extensions using tools from the field of fluid
dynamics [5], [28]. Previously, Elkin et al. [10] considered
a regularization of the Benamou-Brenier OMT formulation
[1] by adding a diffusion term to the Euler equation in their
framework (see our discussion below). The study of the result-
ing velocity field was carried out in an Eulerian framework,
i.e. flow properties are considered at specific locations for
Rena Elkin is with Department of Applied Mathematics and Statistics,
Stony Brook University, NY, USA 11794-2242.
Email: rena.elkin@stonybrook.edu
Saad Nadeem is with Department of Medical Physics, Memorial Sloan-
Kettering Cancer Center, NY, USA 10065. Email: nadeems@mskcc.org
Hedok Lee and Helene Benveniste are with Department of Anesthesiology,
Yale School of Medicine, New Haven, CT, USA 06519.
Email: {hedok.lee,helene.benveniste}@yale.edu
Allen Tannenbaum is with Departments of Computer Science and Applied
Mathematics & Statistics, Stony Brook University, NY, USA 11794-2242.
Email: arobertan@cs.stonybrook.edu
each time point as compared to the Lagrangian framework,
which tracks specific particles as they move over time; see
Figure 1. Due to the unsteady nature of the flows, it will be
advantageous to also consider taking a Lagrangian approach to
this regularized flow. The trick to do this is based on the theory
of Schro¨dinger bridges; see [7] and the references therein. In
this work, we consider the glymphatic system from this point
of view. It turns out that there are two equivalent ways to derive
the Lagrangian coordinates of the optimal trajectories.The first
is via a transformation of the advection-diffusion equation in
the regularized problem, and the second by adding a Fisher-
Rao information type term to the kinetic energy in [1]; see
our discussion below. In either case, employing Lagrangian
coordinates appears to give greatly improved visualizations of
glymphatic system function and also reveals new disparate
transport features in two different states of arousal that were
previously difficult to discern. We should note that previously
we considered an Eulerian approach without diffusion in
Ratner et al. [32]. Because of the lack of diffusion in our
model, we were essentially tracking noise in the later frames
of our image sequences for the glymphatic system.
Waste products are removed from the brain through the
glymphatic system (GS); a peri-vascular transit passage for
cerebrospinal fluid (CSF) which facilitates mixing of CSF
with interstitial fluid (ISF) via aquaporin 4 water channels
positioned on glia cell’s end-feet [18]. Lack of sufficient waste
clearance attributed to aberrant glymphatic function has been
associated with the pathology of a rising number of neuro-
logical conditions including vascular dementia, Alzheimer’s
Disease (AD) [29] and sleep deprivation [33]. Poor sleep
architecture has been associated with greater accumulation of
the metabolic waste product amyloid beta (Aβ) in the human
brain [35] and higher risk for AD and other dementias [2],
[37].
The GS has been shown to accelerate waste clearance from
the brain during slow wave sleep and anesthesia when com-
pared to wakefulness [41]. It has been hypothesized therefore
that the brain’s homeostatic need to clear metabolic waste
serves as a biological driver for sleep. Preservation of GS
function therefore has prodigious implications for maintaining
general brain health across the age span. Interestingly, it was
assumed that all drug-induced sleep states would increase GS
function to the same extent when compared to wakefulness
[41]. This concept, however, was challenged, as it was recently
shown that unconsciousness induced with dexmedetomidine
(DEXM) that mimics natural sleep enhances GS function to
a greater extent when compared to deep anesthesia induced
with isoflurane [3]. These results infer that hypnotic drugs that
promote ‘natural’ sleep might be superior to deeper states of
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2sleep/anesthesia regarding preservation of GS function. Novel
ways to improve or maintain GS function for general brain
health is urgently needed and dependent on developing robust
analysis tools to quantify its function.
The main contributions of this work are as follows:
1) We present a Lagrangian framework for analyzing flows
derived from a regularized dynamical OMT problem.
2) For studying the glymphatic system, one must consider
rather small diffusions. Employing the equivalence be-
tween the regularized dynamical OMT problem and the
Fisher-Rao regularization, we can naturally handle this
in our framework. This is in contrast to the Sinkhorn
method for entropic regularization [9], which becomes
unstable for small diffusive values. We should note
that several authors have considered modifications of
Sinkhorn in order to get smaller values of the scaling
parameter; see [34], [38] and the references therein. Nev-
ertheless, because of the nature of the scaling, Sinkhorn
type algorithms will fail to be stable for sufficiently
small values of the diffusion parameter.
3) We successfully differentiate between glymphatic flows
under two different anesthetics and provide additional
flow attributes and insights that align with the biological
understanding.
The Lagrangian methodology described in the present work
is of course general and may be applied to any flow problem
for which the regularizied OMT methodology is relevant; see
Figure 2. In our case, our interest is primarily in the glymphatic
system and other medical applications which include problems
related to tumor vascularization, tractography, and autism [16].
This paper is organized as follows. In Section II, we provide
a brief review of the OMT problem. We then present our
Lagrangian framework for the regularized OMT problem in
Section III, followed by a formal presentation of the fluid
model with special considerations for medical images, and the
GS in particular, in Section IV. Results with the numerical
implementation of our Lagrangian framework are then shown
in Section V before ending with a few comments about future
directions in Section VI.
II. BACKGROUND
Optimal Mass Transport
As alluded to above, the problem of optimal mass transport
(OMT) is concerned with moving mass from one site to
another so that minimal ‘work’ is expended, and mass is
preserved. The problem was originally put forth by Gaspard
Monge [26], and much later relaxed by Leonid Kantorovich
via the use of joint distributions [20]. In recognition of this,
the modern formulation of the OMT problem is known as the
Monge-Kantorovich problem (MKP). In the present work, we
will use the terms OMT and MKP interchangeably. Recently,
there have been a huge number of theoretical advancements
together with applications to a wide array of disciplines [11],
[30], [31], [39]. In particular, Brenier’s work using polar
factorization to characterize optimal transport plans [4] led to
an extension of the formalism to partial differential equations
[6], [11]–[14]. This has proven to be a remarkable tool
Fig. 1. Illustration of Eulerian and Lagrangian visualizations of flow dynamics
(Eulerian) Streamlines are computed at a fixed set of initial locations for
each time point independently. The streamlines are then clustered in order
to extract streamlines representative of the flow. Time-varying flow behavior
can be observed by comparing streamlines with the same starting point at
different instances of time, as shown in 1(A). Here, color is used to distinguish
streamline clusters and the time axis points from left to right and then proceeds
to the row below. Alternatively, (Lagrangian) temporal changes in particle
trajectories are encompassed by pathlines, clustered in the same manner, and
presented in a single image 1(B). Time-varying particle attributes associated
with the pathlines, such as density and speed depicted respectively in 1(C)
and 1(D), exemplify the simplistic yet informative nature of our unified
visualization framework.
for the study and visualization of flows, creating renewed
interest in the MKP (OMT). For an historical account of
the transportation problem and its extensions, see [21] and
references therein. For our purposes with respect to medical
images, we recall the MKP for smooth densities defined on
domains in Euclidean space.
Let µ0 and µ1 be non-negative density functions over a
bounded, connected subspace R of Rd with the same total
mass ∫
R
µ0(x) dx =
∫
R
µ1(x) dx, (2.1)
for x ∈ R. We then consider mass preserving diffeomorphisms
ξ : R → R describing how the mass distributed according to
µ0 should be moved in order to match the distribution µ1,
namely those satisfying the Jacobian equation
µ0 = det(Dξ)µ1 ◦ ξ, (2.2)
where Dξ denotes the Jacobian of ξ.
In general, there may be many solutions to the Jacobian
equation whose set of solutions we denote by MP . We seek to
find an optimal one in some sense, which brings us to optimal
mass transport. Namely, the Lp-MKP problem is given by
finding
inf
ξ∈MP
∫
R
µ0(x)‖x− ξ(x)‖p dx. (2.3)
One may consider more general costs in the OMT formulation
[31], [39], but here we take the cost (work) to be of the form
‖x− ξ(x)‖p. The most relevant cases are of course p = 1, 2.
For fluid flow problems, and to guarantee uniqueness, we will
only consider p = 2 in the present work. Indeed, Brenier [4]
shows that the optimal map satisfying the MKP (2.2–2.3) is
unique and has the form
ξMK = ∇ηMK , (2.4)
where ηMK is strictly convex (in other words, the optimal
transport map is curl free); see [14], [40] for a proof. Substi-
3tuting the transport map of the form (2.4) into the constraint
(2.2) yields the following Monge-Ampere equation
det(Hη) =
µ0
µ1 ◦ ∇η , (2.5)
where Hη denotes the Hessian of η. As a result, numerical
methods have been developed for solving the Monge-Ampere
equation (2.5) for convex η :R → R, thereby obtaining the
optimal transport map ξMK via the relationship (2.4); see [6],
[11], [12] and the references therein..
For our purposes, perhaps the key approach to the quadratic
MKP problem is due to Benamou and Brenier [1]. They
propose an alternative numerical solution by introducing time
and solving a partial differential equation constrained space-
time minimization problem. This formulation has the geometic
interpretation of finding geodesics [27] between the given
densities µ0 and µ1 in the space of probability densities
and the trajectory of the transport is explicitly factored into
the cost. We will now describe this in some detail, since
our proposed methodology is an extension of the Benamou-
Brenier formulation.
A. Fluid Dynamical Formulation
As referenced above, Benamou and Brenier give the follow-
ing fluid dynamical version of the MKP over the normalized
time interval t ∈ [0, 1] [1]:
inf
µ,ν
∫ 1
0
∫
R
µ(t, x)‖ν(t, x)‖2 dx dt (2.6)
subject to ∂tµ+∇ · (µν) = 0 (2.7)
µ(0, ·) = µ0(·), µ(1, ·) = µ1(·), (2.8)
where µ = µ(t, x) ∈ R is the density interpolant between the
given densities µ0 and µ1, assumed to have the same total mass
(2.1), and ν = ν(t, x) ∈ Rd is the velocity. Here we consider
the kinetic energy (up to a factor of 1/2) associated with the
transport (2.6) and require that the time-varying densities and
velocities satisfy the continuity equation (2.7) with temporal
endpoints matching the given densities (2.8) to enforce mass
conservation.
The optimal µBB and νBB so that the infimum (2.6) is
achieved do exist. In terms of Lagrangian coordinates, the
trajectory X(t, x) of a particle with initial position x ∈ R
is given for time t ∈ [0, 1] by
X(0, x) = x, ∂tX = νBB(X(t, x), x). (2.9)
Moreover, the formulations given by (2.2–2.3) and (2.6–2.8)
are equivalent [1], [39] in the sense that they both yield the
same transport cost and for any x ∈ R we have,
X(1, x) = ξMK(x). (2.10)
Indeed, the geodesics described by (2.9) can be parameterized
as follows,
X(t, x) = x+ t(ξMK(x)− x), (2.11)
where ξMK is the optimal transport map for the MKP.
B. Regularized OMT
Explicit representation of the density’s evolution suggests
exciting capabilities for improved image registration tech-
niques to account for dynamical aspects of physiological
processes with additional aptitude for analyzing interesting
time-varying phenomena. This is particularly powerful for
medical applications where a complete physical model is often
impractical to implement. Following [10], we modify the
original Benamou and Brenier OMT formulation by adding
a diffusion term in the continuity equation to better model
both advection and diffusion of the contrast agent. Further,
the diffusion term regularizes the flow, and leads to smoother
pathways when visualizing the glymphatic system.
Accordingly, we consider the following regularized OMT
problem which will be used to motivate a Lagrangian frame-
work for flow representation developed in the next section
inf
µ,ν
∫ 1
0
∫
R
µ(t, x)‖ν(t, x)‖2 dx dt (2.12)
subject to ∂tµ+∇ · (µν) = ∆µ, (2.13)
µ(0, ·) = µ0(·), µ(1, ·) = µ1(·) (2.14)
 > 0. (2.15)
It is interesting to note that this may also be regarded as a
reformulation of the Schro¨dinger bridge problem [7] as we
will indicate below.
III. LAGRANGIAN COORDINATES
We can define the optimal trajectory in Lagrangian coordi-
nates for the regularized case as follows. Let µmin and νmin
denote the minimum arguments of the action (2.12) subject to
(2.13). Define the augmented velocity
νˆ(t, x) = ν(t, x)− ∇ logµ(t, x). (3.16)
Noticing that
∇ · (µνˆ) =∇ · [(ν − ∇ logµ)µ] (3.17)
=∇ · (µν)− ∇ · (µ∇ logµ) (3.18)
=∇ · (µν)− ∆µ, (3.19)
we get the following conservation form of the constraint
(2.13):
∂tµ+∇ · (µνˆ) = 0. (3.20)
Analogous to (2.9), the Lagrangian coordinates of the flow
X = X(t, x) corresponding to the minimizing velocity νmin
is the solution of the differential equation
X(0, x) = x, ∂tX = νˆmin(t,X(t, x)), (3.21)
where according to (3.16)
νˆmin = νmin − ∇ logµmin. (3.22)
4A. Fisher-Rao regularization
It is very important to note that the regularized OMT
problem is equivalent to a Fisher-Rao information theoretic
regularization of OMT, which is very closely connected to the
Sinkhorn approach [9], and is in fact a dynamic formulation
of the Schro¨dinger bridge problem [7]. For small  in the
advection-diffusion equation above, Sinkhorn will become
unstable, which is why one needs to employ a different
approach in the medical imaging realm. We will therefore
derive an equivalent Lagrangian formulation of regularized
OMT via the Fisher-Rao regularized functional. We should
note that there are a number of works demonstrating the
equivalence of Fisher-Rao and OMT joint interpolation func-
tional and regularized OMT including [7], [8], [24], [25]. We
include some of the details of the computation since these are
used in the numerical implementations given below, and the
Lagrangian approach for studying the glymphatic system.
Following the notation of the previous section, we claim
that the problem defined by (2.12–2.15) is equivalent to
inf
µ,νˆ
∫ 1
0
∫
R
µ(t, x)(‖νˆ(t, x)‖2 + 2‖∇ logµ(t, x)‖2) dx dt
+2H(µ1‖µ0) (3.23)
subject to ∂tµ+∇ · (µνˆ) = 0, (3.24)
µ(0, ·) = µ0(·), µ(1, ·) = µ1(·), (3.25)
for time-varying densities µ = µ(t, x) ∈ R and velocities
ν = ν(t, x) ∈ Rd where
H(µ1‖µ0) :=
∫
R
µ1(x) logµ1(x)− µ0(x) logµ0(x) dx.
(3.26)
Clearly, H(µ1‖µ0) is a constant.
Noting that
νˆ(t, x) + ∇ logµ(t, x) = ν(x, t), (3.27)
and ∫ 1
0
∫
R
µ(t, x)‖νˆ(t, x) + ∇ logµ(t, x)‖2 dx dt
=
∫ 1
0
∫
R
µ(t, x)‖νˆ(t, x)‖2
+ 2µ(t, x)〈νˆ(t, x),∇ logµ(t, x)〉
+ 2µ(t, x)‖∇ logµ(t, x)‖2 dx dt,
(3.28)
we see that the claim will be verified once we show that
J :=
∫ 1
0
∫
R
〈µνˆ,∇ logµ〉 dx dt = H(µ1‖µ0). (3.29)
However, using integration by parts (i.b.p.) and equa-
tions (3.24-3.25) we see that
J = −
∫ 1
0
∫
R
∇ · (µνˆ) logµdx dt (3.30)
=
∫ 1
0
∫
R
∂tµ logµdx dt again using i.b.p. (3.31)
= −
∫ 1
0
∫
R
µ∂t(logµ) dx dt+H(µ1‖µ0). (3.32)
Fig. 2. Schematic of Lagrangian OMT pathline formulation: The given initial
and final noisy images µ˜0 and µ˜1 are fed as input into the generalized
regularized OMT algorithm (GR-OMT), which then returns the ‘true’ time-
varying density interpolant µ(t, x) and velocity ν(t, x). The GR-OMT output
is subsequently passed to the Lagrangian pathline and particle attribute
algorithm (LPPA) along with pathline seeding points xl, which yields the
pathlines X(t, xl), pathline cluster indeces Cl and particle attributes such as
Xµ(t, xl) and Xν(t, xl).
Therefore, we will be done once we show that∫ 1
0
∫
R
µ∂t(logµ) dx dt = 0. (3.33)
But ∫ 1
0
∫
R
µ∂t(logµ) dx dt=
∫ 1
0
∫
R
µ
∂tµ
µ
dx dt (3.34)
=
∫
R
(µ1(x)−µ0(x)) dx (3.35)
= 0 (3.36)
since the total masses of µ1 and µ0 are equal.
Remarks:
(i) Letting νˆmin denote the optimal vector field for (3.23-
3.24), the Lagrangian coordinate solution is then exactly
that given by (3.21) above.
(ii) As in the classical OMT setting, the optimization prob-
lem (3.23-3.24) admits an equivalent static formulation
which amounts to minimizing a certain relative entropy
functional. As noted above, there are very fast algo-
rithms for solving such entropic regularized versions of
OMT for sufficiently large  [9]. Since, as we will see,
we will need to consider small values , we will need to
apply an algorithm from [36] that we will detail below.
IV. FLUID MODEL FOR GLYMPHATIC SYSTEM
Suppose we are given dynamic contrast enhanced (DCE)
images
{µ˜tm : R → R+ ∪ {0}}Mm=0, (4.37)
({µ˜tm} for short), over the compact subdomain R ⊂ Rd (here,
we consider d = 3) captured at times tm,m = 0, . . .M ,
normalized so that t0 = 0 and tM = 1. Image intensity is
assumed proportional to contrast agent (tracer) density [22]
and is therefore simply referred to as the density. Our goal is
to model the glymphatic flow that occurs during the period of
time between image acquisition, as captured by the apparent
changes in the image intensity distributions. To this end,
5Algorithm 1 Generalized Regularized OMT
Require: The respective initial and final observed tracer dis-
tributions µ˜0 and µ˜1, the diffusivity 
Ensure: Believed true interpolated tracer distributions µ(ti)
for i = 1, ..., N , the velocity field ν characterizing the tracer
movement subject to the ADE (4.39)
Initialize cell-centered grid;
Initialize the velocity field with guess ν;
for k = 0 to Niter do
Compute the interpolated tracer distributions µ(ti) for i =
1, ..., N according to the ADE (4.39);
Compute the gradient gF (ν) of the objective function
(4.40) with respect to the velocity ν;
Compute the Hessian HF (ν) of the objective function
(4.40) with respect to the velocity ν;
Solve the system
HF (ν)s = −gF (ν)
for the Newton step s;
Perform line search: find α that minimizes F(ν + αs);
ν ← ν + αs;
end for
return the velocity ν
Algorithm 2 Lagrangian Pathlines and Particle Attributes
Require: The optimal time-varying tracer density µ and ve-
locity ν returned from the GR-OMT algorithm 1, the cell-
centered grid spacing δx, time step δt and diffusivity 
used by the GR-OMT algorithm 1, a pathline seeding point
criterion
Ensure: Significant Lagrangian pathlines X , cluster reference
for each pathline Cl, density pathlines Xµ, speed pathlines
Xν
Uniformly select p pathline seeding points xl out of all
voxels that satisfy the given criterion;
Initialize Lagrangian coordinates with particles’ starting
positions: X ← xl;
Initialize time: t← 0;
for all xl do { For all seeding points}
for i = 1 : N do
Update particle attributes:
Xµ ← µ(t,X); { Interpolate density}
ων ← ν(t,X); { Interpolate velocity}
Xν ← ‖ων‖;
Compute augmented velocity (3.16):
νˆ ← ων − ∇ logXµ;
X ← X + δtνˆ; { Update particle position}
t← t+ δt; { Update time}
end for
end for
Cluster pathlines by proximity with similar curvature and
get the corresponding cluster index for each pathline Cl;
return Pathlines X , cluster indices Cl, density along
pathlines Xµ, speed along pathlines Xν
implementing the classical OMT problem necessitates that the
density images {µ˜tm} all have the same total mass. However,
this is unrealistic due to noise, tracer degradation, changes in
distance of tracer from the sensor, and limitations of sensor
sensitivity. A common approach it to normalize the densities
to enforce total mass conservation. However, this is difficult
to do for large data like medical images and enhances the
effects of the aforementioned inaccuracies which then may
drastically influence the derived transport map. Following [10],
we modify the above set-up slightly in consideration of noise
and unbalanced densities as is expected for DCE images.
We preface the model formulation with the following as-
sumptions regarding the data:
First, we assume that the density images {µ˜tm} are noisy
observations of the tracer’s true states
µ(tm, x) + δ = µ˜tm(x), m = 0, . . . ,M, (4.38)
where x ∈ R, 0 ≤ µ : [0, 1] × R → R is a density
and δ is a random independent, identically distributed (iid)
Gaussian variable with covariance Ξ. Second, we assume
the apparent glymphatic transport is characterized by the
advection-diffusion equation (ADE),
∂tµ+∇ · (µν) = ∆µ, (4.39)
where ν : [0, 1]×R → Rd is the velocity and  ∈ R+ is the
diffusive coefficient.
The generalized regularized OMT problem (GR-OMT) is
then given as follows
inf
µ,ν
F =
∫ 1
0
∫
R
µ(t, x)‖ν(t, x)‖2 dx dt (4.40)
+ γ‖µ(1, x)− µ˜1(x)‖2Ξ
subject to : ∂tµ+∇ · (µν) = ∆µ (4.41)
µ(0, ·) = µ˜0(·) (4.42)
Here, we relax Benamou and Brenier’s final fixed-endpoint
constraint (2.8) and seek the noise free, or ‘true’ tracer density
µ(t, x). The parameter γ is used to determine how heavily
endpoint deviation from the given density should be penalized.
This helps prevent over-fitting to noise in the images and
provides a straightforward way to influence the optimization
with observed states by adding intermediate time steps.
For this work, the GR-OMT is solved numerically using a
discretize-then-optimize approach. Briefly, the ADE (4.41) is
solved using operator splitting so only the initial density µ˜0
and velocity ν are needed to get the density µ(t, x) at any
time point t. In this way, solving the GR-OMT reduces to
minimizing F (4.40) solely with respect to the velocity. This
is done using Gauss-Newton type methods; see Algorithm 1
and [10] for more details.
Finally, we note that exactly as before, we may formulate
the constraint (4.41) in conservation form via the transforma-
tion
vˆ(t, x) = v(t, x)− ∇ logµ(t, x), (4.43)
that allows us to give the same Lagrangian formulation of
the regularized problem (3.21) for the GR-OMT as well. We
have already seen that this transformation is equivalent to the
Fisher-Rao regularization of OMT.
6Pathlines
Elkin et al. [10] utilized an Eulerian framework to analyze
the derived velocity field. This entailed computing streamlines,
i.e., a family of curves that are everywhere parallel to the
velocity vector at a fixed time. Streamlines provide informative
descriptions of the tracer’s movement but require applying
the procedure and individually viewing the trajectories for
multiple time steps. In order to represent the characteristics
of the flow over all time in one comprehensive figure, we
propose using the Lagrangian framework to construct what
are commonly known as pathlines. A pathline X(t, x) with
initial position X(0, x) = x is given by (3.21) and traces
the trajectory of an individual particle throughout the time
interval. Specifically, additional information such as %-signal
from baseline is used to determine regions where flow is more
likely to occur. Throughout this region of interest, p seeding
points, denoted xl, are selected uniformly. Pathlines are then
computed by integrating the augmented velocity (3.16) with
initial positions xl. The speed ‖ν(t,X(t, xl)‖ of each particle
is simultaneously computed along each pathline, referred to
as the speed pathline and denoted Xν = Xν(t, xl), by
(tri)linearly interpolating the GR-OMT derived velocity field
ν. We note that additional particle attributes such as density
can be similarly obtained for further analysis of the flow
dynamics. In order to extract pathlines that are representa-
tive of the flow behavior in specific anatomical regions, we
subsequently cluster the pathlines by proximity and similar
curvature using the QuickBundles algorithm [15]. Each path-
line is returned with an associated cluster index Cl that can
be used to group speed pathlines as well; see Algorithm 2.
Algorithms 1 and 2 were implemented in MATLAB and run
on a CPU cluster with 4592 nodes in total (128 gigabytes
RAM per node). All 8 datasets (5 Dex, 3 Iso) of resolution
128× 128× 128 took approximately 10 hours to run.
V. DISCUSSION
While streamlines and pathlines are interchangeable for
steady flows (i.e. time independent), the same cannot be said
for unsteady flows (i.e. time dependent). A novel aspect of
the Benamou-Brenier [1] dynamical OMT formulation is its
explicit description of the density’s time-varying evolution,
suggesting the need for Lagrangian analysis of this behavior.
The Lagrangian approach provides an elegant framework to
observe various attributes such as speed and density along
the pathlines. Having a single representation for the history
of a particle and its attributes across time lends itself to a
natural means for differentiating between flows under different
conditions. We show the capability of this framework as it
pertains to the GS.
Glymphatic transport can be observed with dynamic con-
trast enhanced magnetic resonance imaging (DCE-MRI) in
combination with administration of paramagenetic contrast
agents (e.g. DOTAREM) into the CSF [23]. However, supple-
mentary analysis is required in order to extract and distinguish
characteristics of the GS transport patterns and flow. Current
techniques for quantifying GS transport include assessment
of brain parenchymal solute uptake or clearance [18], kinetic
analysis [23], and k-means cluster analysis [17], [19]. All of
these analytical strategies are useful and have provided valu-
able information but are limited. Kinetic and cluster analysis
strategies provide a static ‘snapshot’ of GS transport over 2-3
hours and dynamic information is lost. Solute uptake analysis
only informs on GS ‘influx’ and visualization of the dynamic
transport patterns in the brain are not derived [17], [23].
As briefly mentioned above, Elkin at al. [10] applied OMT
analysis to study GS transport in the rat brain based on
DCE-MRIs and were able to discern two new GS transport
features not previously captured: Dynamic CSF streamlines
penetrating into the brain parenchyma as well as new solute
exit (drainage) pathways. Here, we present an improved La-
grangian framework for analyzing GS transport flows derived
from a regularized dynamical OMT problem. We apply this
new analytical pipeline to measure GS function based on DCE-
MRIs acquired in rats while under two different states of
unconsciousness - ‘light’ sleep/hypnosis with DEXM versus
deep sleep/anesthesia with isoflurane based on data from [3].
Specifically, we tested the new Lagrangian OMT framework’s
ability to differentiate GS function between these two different
states of arousal.
Cluster pathlines derived from our Lagrangian framework
are shown in Figure 3. It is evident, based on the cluster
pathlines patterns observed in the rats anesthetized with the
two anesthetics, that glymphatic transport function is very
different. With DEXM anesthesia, glymphatic transport in the
brain is highly efficient as noted by the density of cluster
pathlines reaching into the hippocampus, hypothalamus and
the brain stem. In contrast, in the rat anesthetized with isoflu-
rane, glymphatic transport is inhibited and CSF (and cluster
pathlines) is not penetrating as much into brain parenchyma.
This is most clearly visualized by the vigorous and premature
‘exit’ of CSF along the olfactory nerves (cobalt blue clusters),
which over 30 minutes is very prominent in the ISOFLURANE
but not in the DEXM anesthetized rat.
Figure 4 captures pathline speed (integrated over 30 min-
utes) through the GS in rats anesthetized with either DEXM
or isoflurane. The speed pathlines associated with the whole
brain are shown as a 3D volume rendered color-coded map
overlaid on the corresponding 3D volume rendered anatomical
rat brain. Higher and lower magnitudes of speed in a given
pathline are represented by red and blue colors, respectively.
Note that with both anesthetics, pathline speed is lower in
areas associated with the basal cisterns and higher towards the
olfactory bulb and frontal cortex. In the isoflurane anesthetized
state, pathline speed is high along the olfactory nerves. In the
DEXM anesthetized rats, only a few speed lines reach out into
the nasal cavity, however, their speed appears to be identical to
those of the isoflurane anesthesia. In Figure 5, we have listed
the average speed in each of the clusters defined in Figure 4.
As can be observed, the average speed in clusters within the
key anatomical areas appears to be within the same range for
the two anesthetics. It is interesting to note that the speed of
pathlines within the olfactory bulb versus along the olfactory
nerves is similar. This new analytical modality provides a
way to capture GS features which have not previously been
revealed.
7Fig. 3. Glymphatic transport is visualized using cluster pathlines derived
from the Lagrangian framework analysis. This approach now allows us to
view the glymphatic transport over 30 minutes in one figure. Specifically,
the figure shows glymphatic transport of DOTA (Gd-Dota) in the brains of
rats during anesthesia with DEXM (Figures 3B-D) and Isoflurane (Figures
3E-H). 3A, B, E, F: 3D volume rendered rat brains with color coded cluster
pathlines overlaid. In 3A and 3E, the 3D brain is solid-appearing, so that
only cluster pathlines on the surface entering or exiting the brain can be
highlighted. In 3B and 3F, the brain parenchyma has been rendered transparent
so that cluster pathlines penetrating into the tissue can be appreciated. Each
cluster is color coded to highlight anatomical areas of interest: Turquoise:
cluster pathlines associated with the cisterna magna (CM) and spinal cord.
Blue: cluster pathlines associated with the basal cisterns; Magenta: cluster
pathlines associated with CSF penetrating into the ventral hippocampus; Red:
cluster pathlines associated with CSF surrounding the pineal recess; Purple:
cluster pathlines associated with the hypothalamus and ventral surfaces; Cobalt
blue: cluster pathlines associated with the olfactory bulb; Green: Cluster
pathlines associated with the rhinal fissure (RF). 3C-D, 3G-H are 2D T1-
weigthed MRIs of each rat presented in the sagittal plane showing anatomical
landmarks of interest. Pi=pineal gland; Cb=cerebellum; Spi=spinal cord;
Hyp=hypothalamus; Pit=pituitary; Olf=olfactory.
TABLE I
AVERAGE SPEED CALCULATED IN CLUSTERS WITHIN ANATOMICAL HUBS
Anesthetic Isoflurane (N=3) DEXM (N=5)
Pineal Recess 36.1± 1.4 37.5± 2.4
Hippocampus (Ventral) 43.6± 2.5 41.9± 2.3
Ventral surface 68.7± 2.5 63.0± 5.3
Olfactory 104.7± 14.0 101.6± 3.9
Basal cisterns 30.6± 1.4 28.1± 3.6
Table I provides an estimate of average speed in rats
anesthetized with isoflurane (N=3) and DEXM (N=5) and
confirms that the speed range across groups are identical. Data
are mean ± SD.
VI. CONCLUSION AND FUTURE WORK
We have introduced a Lagrangian OMT framework to
represent time-varying dynamics and various attributes in a
single visualization. A theoretical proof for the connection
between the regularized OMT problem and the Fisher-Rao
Fig. 4. Speed pathlines over 30 minutes of glymphatic transport distinguising
flow behavior under two anesthetics, DEXM (left) and Isoflurane (right).
Fig. 5. 3D volume rendered pathline speed brain maps (representing the first
30 minutes of captured GS transport) are shown from a rat anesthetized with
DEXM (5A) and isoflurane (5C). The corresponding average speed in each of
the anatomical clusters are shown in 5B and 5D. The magnitude of pathline
speed is different across anatomical brain regions and observed to be highest
along the ventral surface of the brain, in the olfactory bulb and along the
olfactory nerves. However, for a given anatomical region speed appears to
be within same ranges for the two anesthetics. Hip=Hippocampus; BC=Basal
Cisterns; VS=Ventral surface of brain; Olf=Olfactory.
regularization was also provided which allows efficient compu-
tation using small diffusive values . The resultant framework
was then used to capture known GS transport flow patterns
and provide additional insights in distinguishing GS function
under different anesthetic conditions.
In the future, we will extend the proposed framework to dif-
ferentiate between healthy and pathological (e.g. Alzheimer’s
disease, vascular diseases, autism) cases. Specifically, given
enough datasets, the computed particle attributes can be used
as features in machine learning algorithms to differentiate and
8classify various transport related flow patterns for diagnostic
purposes. Moreover, we will also add a source term into the
GR-OMT formulation to account for dynamics during tracer
infusion; this will allow us to identify tracer particles by their
initial position and the first time they appear. This can then
help focus specifically on tracking these particles over time
which naturally suggests using a Lagrangian representation of
their trajectories. With this motivation, we will formulate a
Lagrangian method for solving this regularized (source-term
added) OMT in the future.
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